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abstract
Background: in developing countries, most of these patients with urinary tract infections 
(Uti) are normally treated empirically and urine culture is usual ordered for as a last 
resort in patients refractory to antibiotic treatment.
Objective: to explore the possibility of designing empiric antibiotic therapy for 
symptomatic Uti in patients at aga Khan University hospital by looking at the trends 
of Uti, common pathogens isolated and their antibiotic susceptibility pattern. 
Design: a retrospective clinical-laboratory study. 
Setting: aga Kahn University hospital- nairobi.
Subjects: all positive urine cultures between January and December 2008 were included 
in the study.
Results: a total of 409 urine specimens were retrieved and analysed and 100 cases had 
negative cultures. three hundred and nine cases had positive cultures.  sixty eight point 
seven percent were females while 31.3% were males with a mean age of 31 years. one 
hundred and thirty five out of 409 patients (33%) had classical signs and symptoms. In 
143 (35%) cases E. coli was isolated. the other cultures were organisms other than E. 
coli. there was a higher resistance to clotrimazole in E. coli (71%) as compared to non- 
E. coli organisms (23%). there was a higher resistance rate to nalidixic acid in non-E. 
Coli organisms (35%) and higher resistance rate to augmentin in E. Coli 43 versus 18% 
(c/f non-E.Coli).  forty patients in the study had predisposing factors for Uti.
Conclusions: it is sometimes warranted to start the patient on empiric antibiotic 
treatment before culture results are available. Nitrofurantoin, Cefuroxime, Ciprofloxacin 
have good sensitively rates and are therefore drugs of first choice for the treatment of 
uncomplicated urinary tract infection provided that the contraindications and specific 
precautions are noted. 
introDUction
Urinary tract infection (UTI) is the most common 
condition leading to outpatient visits and is also the 
most common cause of excessive or inappropriate 
antibiotic usage. Sexually active young women 
are disproportionately affected, but several other 
populations, including elderly persons and those 
undergoing genitourinary instrumentation or 
catheterisation are also at risk. An estimated 40 
percent of women report having had a UTI at some 
point in their lives (1). 
 UTIs are the leading cause of gram-negative 
bacteremia. In the United States, these infections 
account for approximately seven million office visits 
and more than one million hospitalisations, for an 
overall annual cost in excess of United States dollars 
one billion (1, 2). UTIs also account for at least 40% of 
all hospital-acquired infections and are in the majority 
of cases catheter-associated (3-5).  
 Micro-organisms can reach the urinary tract by 
haematogenous or lymphatic spread, but there is 
abundant clinical and experimental evidence to show 
that the ascent of micro-organisms from the urethra is 
the most common pathway leading to a UTI, especially 
organisms of enteric origin (that is, Escherichia coli 
and other Enterobacteriaceae). This provides a logical 
explanation for the greater frequency of UTIs in 
women than in men and for the increased risk 
of infection following bladder catheterisation or 
instrumentation (6). A single insertion of a catheter 
into the urinary bladder in ambulatory patients results 
in urinary infection in 1-2% of cases (7).
 Haematogenous infection of the urinary 
tract is restricted to a few relatively uncommon 
microbes, such as Staphylococcus aureus, Candida 
spp., Salmonella spp. and Mycobacterium tuberculosis, 
which cause primary infections elsewhere in the 
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body.  Candida albicans readily causes a clinical 
UTI via the haematogenous route, but is also 
an infrequent cause of an ascending infection if 
an indwelling catheter is present or following 
antibiotic therapy.
 The concept of  bacterial virulence or 
pathogenicity in the urinary tract infers that not all 
bacterial species are equally capable of inducing 
infection. The more compromised the natural 
defence mechanisms (for example, obstruction, 
bladder catheterisation), the fewer the virulence 
requirements of any bacterial strain to induce 
infection. 
 In developing countries, most of these patients 
are normally treated empirically and urine culture is 
usual ordered for as a last resort in patients refractory 
to antibiotic treatment (8).
 The number of bacteria is considered relevant 
for the diagnosis of a UTI. In 1960, Kass developed 
the concept of ’significant‘ bacteriuria (> 105 cfu) 
in the context of pyelonephritis in pregnancy(9). 
In a suprapubic bladder puncture specimen, any 
count of bacteria is relevant. 
 The aim of this study was to explore the 
possibility of designing empiric antibiotic therapy 
for symptomatic UTI in patients at Aga Khan 
University Hospital by looking at the trends of UTI, 
common pathogens isolated and their antibiotic 
susceptibility pattern. 
Material anD MethoDs
This was a retrospective clinical-laboratory study 
comprising of review of laboratory records and 
their correlation with clinical records. Starting 
with the microbiology laboratory records, patients 
were identified. All positive urine cultures between 
January and December 2008 were included in the 
study. This was then followed by a file review.
 Information concerning each case was entered 
in a standard proforma which included: 
Patient file number• 
Age• 
sex• 
Presence or absence of pyuria • 
Type of organism isolated • 
Antibiotic sensitivity pattern of the isolated • 
organism,
Antibiotic used for treatment of patient, • 
Other co morbidities • 
HIV status• 
Signs and symptoms at presentation • 
One hundred controls were also included with no 
growth obtained from urine specimen who had 
signs and symptoms of urinary tract infection.
resUlts
A total of 409 urine specimens were retrieved and 
analysed and 100 cases had negative cultures. Three 
hundred and nine cases had positive cultures. 
Sixty eight point seven  percent were females while 
31.3% were males with a mean age of 31 years. One 
hundred and four cases were in the pediatric age 




Std. Dev = 22.758
N=327
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The classical signs and symptoms of urinary tract 
infection include:
Lower abdominal pain• 
Dysuria• 
Frequency• 
One hundred and thirty five  out of 409 patients (33%) 
had classical signs and symptoms. 
 The complaints of the other 274 patients included 
non-specific symptoms such as lower abdominal pain 
(8.6%), chills/fever (10.3%), haematuria (0.2%) and 
others, and urine microscopy results showed WBC 
> 5/HPF (pyuria) in 54.3% of the cases.
 In 143 (35%) cases E. coli was isolated. The other 
cultures were organisms other than E.coli as displayed 
in Table 1.
table 1




Aeromonas hydrophila 4 0.9
Aeromonas iwoffi 1 0.2
C.albicans/Streptococcus spp. 1 0.2




Gram negative bacilli 1 0.2
Klebsiella oxytica 1 0.2
Klebsiella pneumoniae 3 0.7
Klebsiella terrigena 1 0.2
Kluvera 19 4.6
Mycoplasma 1 0.2
No growth  101 24.7
Pseudomonas auregenosa 9 2.1
Proteus Mirabilis 4 1.0
Proteus vulgaris 4 1.0
Providencia 1 0.2
Streptococcus agalactiae 11 2.6
Staphylococcus aureus 15 3.7
Staphylococcus epidermidis 10 2.4
Staphylococcus epidermidis /C.albicans 1 0.2
Staphylococcus saprophyticus 4 1.0
Streptococcus spp. 1 0.2
Total 409 100.0
Key
ORSA –Oxacillin resistant Staphylococcus aureus
ORSE -Oxacillin resistant Staphylococcus epidermidis
ORSS -Oxacillin resistant Staphylococcus saprophyticus
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The antibiotic resistance proportions of E.coli and 
non- E.coli organisms to the various antibiotics are 
displayed in Table 2. Upto 70% of the E.coli were 
resistant to Septrin. 
 Relating to Pyuria, 59.7% of the females had 
pyuria as compared to 40.8% of males. Patients 
were arbitrarily divided into three age groups; 
<10, 11-50, 51-90. Pyuria was observed mainly in 
patients <10 years and age followed by patients in 
the age group 31-40 years as further displayed in 
Table 3. The list of antibiotics used for therapy and 
the frequency of their usage is displayed in Table 4. 
table 2
Antibiotic Resistance patterns 
Antibiotics Resistant  Resistant
Tested  E.coli % Non- E.coli 
               organisms %
Septrin 101(71) 60(23)
Augmentin 62(43) 47(18)









Age category and pyuria
Age Category Pyuria  Pyuria Total
 Yes No
<10 40 47 87
11-20 8 9 17
21-30 23 30 53
31-40 45 27 72
41-50 18 18 36
51-60 9 9 18
61-70 10 10 20
>70 18 6 24
Total 171 156 327
table 4
Antibiotics used for therapy
















 Forty one patients in the study had predisposing 
factors for UTI. Ten patients were pregnant, one 
had a history of recent catheterisation and one had 
a Foley Catheter in situ. Four patients had diabetes 
mellitus while nine had hypertension. Six had 
chronic obstructive airway disease while nine were 
positive for the human immunodeficiency virus. 
Three patients had a history of recurrent urinary tract 




Co-morbid Frequency  Percent
Depression 1 2.4
Diabetes mellitus 4 9.8
Hypertension 9 22.0
Urinary catheter 10 24.4
Cancer 3 7.3
Pregnancy 10 24.4
Ischaemic heart disease 1 2.4
Trauma 1 2.4
Sickle cell disease 1 2.4
Urinary tract malformation 1 2.4
Chronic obstructive 
Airway disease 6 14.6
Recurrent UTI 3 7.3
Tuberculosis  1  2.4
HIV  9 2.2
Total 51 100.0
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DiscUssion
Normal urine is sterile. An infection occurs when 
gastrointestinal commensals colonise  the urethra 
and begin to multiply. Majority of  infections are 
due to  E. coli. The urinary system is structured in 
a way that prevents entry of infection. The ureters 
and bladder normally prevent urine from backing 
up toward the kidneys, and the flow of urine from 
the bladder help wash bacteria out of the body(10, 
11).The highest incidence of urinary tract infection in 
our study was in females aged 20-40. Female patients 
have more UTI than male patients. Women are more 
prone to UTIs because their urethra is much shorter 
and closer to the anal opening than in males, and 
they lack the bacteriostatic properties of prostatic 
secretions. Among the elderly, UTI frequency in both 
sexes is roughly in equal proportions (11). 
 In our study urinary tract infections in males 
was frequently observed in older men> 50years. This 
is due, in part, to an enlarged prostate in older men. 
Urinary tract infections most commonly occur in 
older men with prostatic disease, outlet obstruction 
or urinary tract instrumentation. These infections 
occasionally occur in young men who participate 
in anal sex (exposure to E. coli in the rectum), who 
are not circumcised (increased E. coli colonisation of 
the glans and prepuce) or whose sexual partner is 
colonised with uropathogens (8, 12). In men (unlike 
in women), a urine culture growing more than 1,000 
CFU of a pathogen per mL of urine is the best sign 
of a urinary tract infection, with a sensitivity and 
specificity of 97 percent(13). 
 E.coli was the most common organism (35%) 
associated with urinary tract infection  in our study 
and this is similar to other studies(20). Escherichia 
coli is the most common cause of uncomplicated UTI 
and accounts for approximately 75 to 95 percent of 
all infections (14-17). A longitudinal study of 235 
women with UTIs found that E. coli was the only 
causative agent in 69.3 percent of cases and was a 
contributing agent in an additional 2.4 percent of cases 
(18). Staphylococcus saprophyticus is a distant second, 
accounting for only 5 to 20 percent of infections. Other 
Enterobacteriaceae, such as Klebsiella and Proteus, 
occasionally cause UTI. Although S. saprophyticus 
is less common than E. coli, it is more aggressive. 
Approximately one half of patients infected with 
S. saprophyticus present with upper urinary tract 
involvement, and these patients are more likely to 
have recurrent infection (14).
 There was a higher resistance to clotrimazole 
(septrin) in E.coli as compared to non- E.coli organisms 
in our study which were more resistant to Nalidixic 
acid. This is most likely due to the fact that most 
Gram positive organisms are relatively resistant to 
Nalidixic acid and it is routinely used as a selective 
medium to suppress Gram positive organisms and 
allow Gram negative isolation. For the above reasons 
clotrimazole and Nalidixic acid are not good choices in 
the empirical treatment of urinary tract infection.
 There was a higher resistance rate to Augmentin 
in E. coli (c/f non-E.coli) in our study. This is possibly 
due to hyper production of Beta-lactamases. In other 
studies up to one third of uropathogens are resistant 
to ampicillin and sulfonamides, but the majority are 
susceptible to trimethoprim-sulfamethoxazole (85 to 
95 percent) and fluoroquinolones (95 percent)(15). 
 This was hardly the case in our study as most 
of our isolates were resistant to trimethoprim-
sulfamethoxazole (septrin) and this may possible 
be due to the increased usage of this drug in HIV 
infected patients as prophylaxis against Pneumocystis 
infection. 
 Table 6 compares our results with the Australian 
Outpatients Study (19), Chan’s study(20) and H.K. 
Chan study. It was found that the resistance to 
nitrofurantoin was universally low. Resistance to 
Nalidixic acid was low in the Australian Outpatients 
study and H.K. Chan study (21), but higher in Chan’s 
study and our study. On the other hand, resistance 
to ampicillin is high both in H.K. Chan study  and in 
Chan’s study, but lower in the Australian Outpatients 
study and our study. Resistance to Cotrimoxazole 
varied significantly, namely 24, 70 , 41 and 52% (Table 
6).
table 6
Comparison of Antibiotic Resistance (%) amongst Three Different UTI Studies
Antibiotic Australian outpatients S.P. Chan study H.K. Chan study Our study
Ampicillin 45 69 61 35
Septrin 24 70 41 52
Nitrofurantoin 0 2 0 11
Nalidixic acid 2 28 2 44
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Pyuria was most common seen in females 59.7% as 
compared to males 40.8% and it was also observed 
in younger patients < 10 years of age and in young 
adults too (31-40 years). UTI occurs nearly 50 times 
more often in women than men under the age of 50 
and increases in both men and women over age 50, 
with the female-to-male ratio decreasing as prostate 
disease becomes more prevalent among older men 
(22). This would explain why the incidences of pyuria 
were higher in the females in our study.
 Between ten and twenty percent of patients 
who are hospitalised receive an indwelling Foley 
catheter. Once this catheter is in place, the risk of 
bacteriuria is approximately five percent per day. With 
long-term catheterisation, bacteriuria is inevitable. 
Catheter-associated urinary tract infections account 
for 40 percent of all nosocomial infections and are the 
most common source of gram-negative bacteremia 
in hospitalised patients (23). In our study 24% of 
the patients had catheter associated urinary tract 
infections (24).
 In our study ten had urinary tract infection in 
pregnancy. Symptomatic urinary tract infections 
complicate one to two percent of pregnancies, usually 
in women with persistent bacteriuria (25-27). Most 
pregnant women with pyelonephritis should be 
hospitalised. Initially, these patients should receive 
intravenous antibiotic therapy. They should complete 
a 14-day course of acute antibiotic therapy followed 
by nightly suppressive therapy until delivery.
In conclusion, one should obtain a mid-stream urine 
from patients suspected to have UTI, for culture and 
sensitivity tests if possible since it is a very important 
guide to treatment. It is sometimes warranted to start 
the patient on empiric antibiotic treatment before 
culture results are available. 
 Ampicillin and Cotrimoxazole (Septrin) should 
not be the first line of empirical treatment since 
resistance was found to be pretty high 35-52%. 
 Resistance to Nalidixic acid was also found to 
be pretty high in non-E. Coli organisms in our study 
and in E. coli in Chan’s study and should therefore 
not be used either as empiric treatment.
 Nitrofurantoin, Cefuroxime, Cefaclor, Ofloxacin 
and Ciprofloxacin have good sensitively rates and 
will therefore be effective first line treatment for 
uncomplicated urinary tract infection provided that 
the contraindications and specific precautions are 
noted. Since the resistance to ampicillin is very high, 
Cephalosporins should be used for the empirical 
treatment of urinary tract infection in pregnancy, 
since they are very effective and relatively safe.
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